1. Home
  2. CRSP vs CE Comparison

CRSP vs CE Comparison

Compare CRSP & CE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$54.91

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Celanese Corporation

CE

Celanese Corporation

HOLD

Current Price

$49.42

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
CE
Founded
2013
1918
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.6B
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
CRSP
CE
Price
$54.91
$49.42
Analyst Decision
Buy
Buy
Analyst Count
17
14
Target Price
$70.29
$64.29
AVG Volume (30 Days)
1.6M
1.4M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
0.18%
EPS Growth
N/A
23.62
EPS
N/A
0.40
Revenue
$289,590,000.00
$9,544,000,000.00
Revenue This Year
$807.72
$3.14
Revenue Next Year
$172.52
$2.83
P/E Ratio
N/A
$122.35
Revenue Growth
9169.85
N/A
52 Week Low
$44.12
$35.13
52 Week High
$78.48
$70.70

Technical Indicators

Market Signals
Indicator
CRSP
CE
Relative Strength Index (RSI) 53.13 35.62
Support Level $50.17 $46.64
Resistance Level $60.10 $49.06
Average True Range (ATR) 2.57 1.98
MACD 0.19 -0.07
Stochastic Oscillator 60.16 24.76

Price Performance

Historical Comparison
CRSP
CE

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About CE Celanese Corporation

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Share on Social Networks: